Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/12/2025

Contrave Naltrexone Dosage Guidelines

Introduction to Contrave

  • The American College of Clinical Gastroenterology recommends a maintenance dose of Contrave for obesity management of 32 mg naltrexone/360 mg bupropion daily, which translates to 4 tablets per day (2 tablets twice daily) 1, 2

Dosing Schedule

  • The maintenance dose of Contrave for obesity management is 32 mg naltrexone/360 mg bupropion daily, which translates to 4 tablets per day (2 tablets twice daily) 1, 2
  • The week-by-week titration protocol for Contrave is as follows:

Critical Safety Considerations

  • The American Heart Association recommends avoiding Contrave in patients with uncontrolled hypertension, as both components can elevate blood pressure 1, 2
  • The American Academy of Neurology recommends avoiding Contrave in patients with seizure disorders or conditions predisposing to seizures, as bupropion lowers seizure threshold 1, 2
  • The American College of Obstetricians and Gynecologists recommends avoiding Contrave in women who are or may become pregnant 2
  • The National Institute of Mental Health recommends monitoring patients for neuropsychiatric symptoms, particularly suicidal ideation, when taking Contrave 2

Dose Adjustments for Organ Impairment

  • The National Kidney Foundation recommends reducing the total daily dose of Contrave by 50% in patients with moderate to severe renal impairment 1, 2
  • The American Association for the Study of Liver Diseases recommends a maximum dose of 8 mg naltrexone/90 mg bupropion once daily (1 tablet daily) in patients with moderate to severe hepatic impairment 1, 2

Monitoring Requirements

  • The American Heart Association recommends monitoring blood pressure and heart rate periodically, especially during the first 12 weeks, as transient increases of approximately 1.5 mm Hg may occur initially 1, 2
  • The National Institute of Diabetes and Digestive and Kidney Diseases recommends assessing efficacy at 12 weeks, and discontinuing Contrave if less than 5% weight loss is achieved 1

REFERENCES

2

Bupropion Dosing and Administration [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026